Emma Budd
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 11
-
- Osteoarthritis Treatment and Mechanisms 8
- Co-authors
- Ali Mobasheri (7 shared papers)Susan Hopkins (10 shared papers)Diane Ashiru‐Oredope (7 shared papers)Jodi A. Lindsay (3 shared papers)Gwenan M. Knight (3 shared papers)Berit Müller‐Pebody (6 shared papers)Alex Bhattacharya (4 shared papers)Eiva Bernotienė (2 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (6 papers)Advances in experimental medicine and biology (2 papers)Eurosurveillance (2 papers)Osteoarthritis and Cartilage (2 papers)Scientific Reports (1 paper)
- Partner nations
- United KingdomUnited StatesLithuania
In The Last Decade
Emma Budd
22 papers receiving 827 citations
Peers
Comparison fields: 5 of 106
- Applied Microbiology and Biotechnology 274
- Molecular Medicine 99
- Clinical Biochemistry 120
- Geriatrics and Gerontology 53
- Rheumatology 201
Countries citing papers authored by Emma Budd
This map shows the geographic impact of Emma Budd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Budd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Budd more than expected).
Fields of papers citing papers by Emma Budd
This network shows the impact of papers produced by Emma Budd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Budd. The network helps show where Emma Budd may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma Budd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 114 | |
| 2 | 2014 | 90 | |
| 3 | 2018 | 87 | |
| 4 | 2018 | 66 | |
| 5 | 2018 | 55 | |
| 6 | 2016 | 55 | |
| 7 | 2019 | 52 | |
| 8 | 2021 | 48 | |
| 9 | 2018 | 43 | |
| 10 | 2017 | 42 | |
| 11 | 2016 | 29 | |
| 12 | 2016 | 27 | |
| 13 | 2017 | 26 | |
| 14 | 2012 | 19 | |
| 15 | 2013 | 19 | |
| 16 | 2018 | 18 | |
| 17 | 2024 | 15 | |
| 18 | 2017 | 14 | |
| 19 | 2018 | 10 | |
| 20 | 2020 | 3 |
About Emma Budd
Emma Budd is a scholar working on Applied Microbiology and Biotechnology, Rheumatology, Infectious Diseases, Clinical Biochemistry and Pharmacology, having authored 24 papers that have together received 835 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (11 papers), Osteoarthritis Treatment and Mechanisms (8 papers), Bacterial Identification and Susceptibility Testing (5 papers), Inflammatory mediators and NSAID effects (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Patient Satisfaction in Healthcare (3 papers), MicroRNA in disease regulation (2 papers) and Mesenchymal stem cell research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (274 citations), Molecular Medicine (99 citations), Clinical Biochemistry (120 citations), Geriatrics and Gerontology (53 citations) and Rheumatology (201 citations). Emma Budd has collaborated with scholars based in United Kingdom, United States and Lithuania. Frequent co-authors include Ali Mobasheri, Susan Hopkins, Diane Ashiru‐Oredope, Jodi A. Lindsay, Gwenan M. Knight, Berit Müller‐Pebody, Alex Bhattacharya, Eiva Bernotienė, Ilona Uzielienè and Tim Planche. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Advances in experimental medicine and biology, Eurosurveillance, Osteoarthritis and Cartilage and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.